FOLH1 and posterior cortical atrophy: At present, some studies have attempted to develop such molecules for the treatment of PCa, such as the immunotoxin A5-PE40, which showed therapeutic efficacy in animal tumor models [25], and the development of immunotoxins targeting PSMA is a new strategy to treat PCa.